Johns Hopkins Is Training the Next Generation of Psychedelic Researchers Through Its Student Internship Program
The field of psychedelic medicine is growing faster than the workforce trained to support it. Johns Hopkins University is addressing that gap directly. The Center for Psychedelic and Consciousness Research now offers a structured student internship program that places undergraduates and graduate students inside active clinical trials. The program is building the research pipeline that the field will need as psychedelic therapies move toward mainstream clinical use.
What the Program Offers
Interns gain direct exposure to every stage of clinical trial operations. Responsibilities include participant recruitment and scheduling, data collection and transcription, study material preparation, and in some cases direct participant interaction during sessions. The specific duties depend on which research team the student joins and where each study is in its timeline.
This is not observational. Students work alongside principal investigators on active trials. They handle real data, interact with real participants, and contribute to studies that are shaping the future of psychiatric medicine. For students considering careers in clinical research, psychiatry, or psychedelic science, the experience is difficult to replicate anywhere else.
Most clinics spend 4-6 weeks navigating Spravato REMS certification — chasing paperwork, decoding FDA requirements, and wondering if they missed a step. Our AI-powered REMS Certification Assistant cuts that to one sitting. Get a personalized checklist of exactly what you need, and walk into the REMS portal ready to submit.
Get the REMS Certification Assistant →The Research Teams
The center houses multiple principal investigators, each leading distinct research programs. Frederick Barrett studies the psychological and neurological mechanisms of psychedelic effects and leads clinical trials for major depressive disorder with co occurring alcohol use disorder. Albert Garcia-Romeu examines psychedelics for addiction treatment, including applications for Alzheimer’s disease and Lyme disease.
Sandeep Nayak investigates psychedelics for substance use and mood disorders, including PTSD and opioid use disorder trials. David Yaden studies altered states of consciousness and their therapeutic potential. Ceyda Sayali uses neuroimaging tools including fMRI, EEG, and TMS to explore psychedelic mechanisms at the neural level. Brandon Weiss examines psychological mechanisms of therapeutic change with PTSD and ceremonial plant medicines.
Who Can Apply
The program is currently limited to enrolled Johns Hopkins University students. Ideal candidates come from backgrounds in clinical research, psychiatry, medicine, psychology, public health, cognitive science, or neuroscience. The center looks for self motivation, strong interpersonal skills, professionalism, and a demonstrated passion for behavioral pharmacology research.
Applications are accepted on a rolling basis. Students must commit to a minimum of 10 to 15 hours per week, combining remote and on site work during business hours. Both paid and for credit positions are available, with paid roles typically requiring a greater weekly time investment.
Why This Matters for the Field
Psychedelic assisted therapy requires a specialized workforce. Therapists need training in session facilitation. Researchers need clinical trial experience. Regulatory professionals need to understand the unique challenges of scheduling and compliance. None of these skills are taught in standard academic programs.
Programs like this one at Johns Hopkins are creating the talent pipeline. Students who complete internships here enter graduate programs and careers with hands on experience that sets them apart. As psilocybin, MDMA, and other psychedelic therapies advance through the FDA approval process, the demand for trained professionals will only accelerate.
The Bigger Picture
Johns Hopkins has been at the center of the psychedelic research renaissance since its landmark 2006 psilocybin study. The center has produced some of the most cited research in the field. Its findings on psilocybin for depression, smoking cessation, and existential distress in cancer patients have reshaped the scientific conversation around psychedelic medicine.
This internship program extends that legacy to the next generation. It signals that psychedelic research is not a fringe pursuit. It is an established academic discipline with structured training pathways, institutional support, and a growing body of clinical evidence. For students with the right background and motivation, it represents an opportunity to enter the field at its most formative moment.
The Bottom Line
The Johns Hopkins Center for Psychedelic and Consciousness Research is training students inside active clinical trials studying psilocybin for depression, addiction, PTSD, and more. The program is limited to Hopkins students, accepts applications on a rolling basis, and offers both paid and academic credit positions. As psychedelic medicine moves toward clinical reality, programs like this one are building the workforce that will deliver it.
